APO RESEARCH · REPORT
Nanoemulsions
Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
Product & engineering
Understand the product.
Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.
Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.
Selected research
Industry Research
Nanoemulsions Industry Research Report 2026
Market perspective
Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.
Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.
Read the full market overview
In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.
USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.
In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.
Report Scope
This report quantifies the global Nanoemulsions market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nanoemulsions.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nanoemulsions Market by Company
Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen
Nanoemulsions Segment by Type
Steroids
Anesthetics
NSAIDs
Immunosuppressant
Antiretroviral
Antimicrobials
Vasodilators
Others
Nanoemulsions Segment by Application
Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
Nanoemulsions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanoemulsions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanoemulsions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanoemulsions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nanoemulsions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Steroids
- Anesthetics
- NSAIDs
- Immunosuppressant
- Antiretroviral
- Antimicrobials
- Vasodilators
- Others
Applications
- Pharmaceutical Industrial
- Cosmetic Industrial
- Food Industrial
- Others
Companies covered
- Allergan plc
- AbbVie Inc.
- AstraZeneca Inc.
- Fresenius Kabi AG
- Kaken Pharmaceutical
- GlaxoSmithKline
- Novartis AG
- Sanofi
- B. Braun Melsungen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nanoemulsions by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Steroids
- 2.2.3 Anesthetics
- 2.2.4 NSAIDs
- 2.2.5 Immunosuppressant
- 2.2.6 Antiretroviral
- 2.2.7 Antimicrobials
- 2.2.8 Vasodilators
- 2.2.9 Others
- 2.3 Nanoemulsions by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industrial
- 2.3.3 Cosmetic Industrial
- 2.3.4 Food Industrial
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Nanoemulsions Breakdown Data by Type
- 3.1 Global Nanoemulsions Historic Market Size by Type (2021-2026)
- 3.2 Global Nanoemulsions Forecasted Market Size by Type (2027-2032)
4 Nanoemulsions Breakdown Data by Application
- 4.1 Global Nanoemulsions Historic Market Size by Application (2021-2026)
- 4.2 Global Nanoemulsions Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nanoemulsions Market Perspective (2021-2032)
- 5.2 Global Nanoemulsions Growth Trends by Region
- 5.2.1 Global Nanoemulsions Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nanoemulsions Historic Market Size by Region (2021-2026)
- 5.2.3 Nanoemulsions Forecasted Market Size by Region (2027-2032)
- 5.3 Nanoemulsions Market Dynamics
- 5.3.1 Nanoemulsions Industry Trends
- 5.3.2 Nanoemulsions Market Drivers
- 5.3.3 Nanoemulsions Market Challenges
- 5.3.4 Nanoemulsions Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nanoemulsions Players by Revenue
- 6.1.1 Global Top Nanoemulsions Players by Revenue (2021-2026)
- 6.1.2 Global Nanoemulsions Revenue Market Share by Players (2021-2026)
- 6.2 Global Nanoemulsions Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nanoemulsions Head Office and Area Served
- 6.4 Global Nanoemulsions Players, Product Type & Application
- 6.5 Global Nanoemulsions Manufacturers Established Date
- 6.6 Global Nanoemulsions Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nanoemulsions Market Size (2021-2032)
- 7.2 North America Nanoemulsions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nanoemulsions Market Size by Country (2021-2026)
- 7.4 North America Nanoemulsions Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nanoemulsions Market Size (2021-2032)
- 8.2 Europe Nanoemulsions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nanoemulsions Market Size by Country (2021-2026)
- 8.4 Europe Nanoemulsions Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nanoemulsions Market Size (2021-2032)
- 9.2 Asia-Pacific Nanoemulsions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nanoemulsions Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nanoemulsions Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nanoemulsions Market Size (2021-2032)
- 10.2 South America Nanoemulsions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nanoemulsions Market Size by Country (2021-2026)
- 10.4 South America Nanoemulsions Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nanoemulsions Market Size (2021-2032)
- 11.2 Middle East & Africa Nanoemulsions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nanoemulsions Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nanoemulsions Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Allergan plc
- 12.1.1 Allergan plc Company Information
- 12.1.2 Allergan plc Business Overview
- 12.1.3 Allergan plc Revenue in Nanoemulsions Business (2021-2026)
- 12.1.4 Allergan plc Nanoemulsions Product Portfolio
- 12.1.5 Allergan plc Recent Developments
- 12.2 AbbVie Inc.
- 12.2.1 AbbVie Inc. Company Information
- 12.2.2 AbbVie Inc. Business Overview
- 12.2.3 AbbVie Inc. Revenue in Nanoemulsions Business (2021-2026)
- 12.2.4 AbbVie Inc. Nanoemulsions Product Portfolio
- 12.2.5 AbbVie Inc. Recent Developments
- 12.3 AstraZeneca Inc.
- 12.3.1 AstraZeneca Inc. Company Information
- 12.3.2 AstraZeneca Inc. Business Overview
- 12.3.3 AstraZeneca Inc. Revenue in Nanoemulsions Business (2021-2026)
- 12.3.4 AstraZeneca Inc. Nanoemulsions Product Portfolio
- 12.3.5 AstraZeneca Inc. Recent Developments
- 12.4 Fresenius Kabi AG
- 12.4.1 Fresenius Kabi AG Company Information
- 12.4.2 Fresenius Kabi AG Business Overview
- 12.4.3 Fresenius Kabi AG Revenue in Nanoemulsions Business (2021-2026)
- 12.4.4 Fresenius Kabi AG Nanoemulsions Product Portfolio
- 12.4.5 Fresenius Kabi AG Recent Developments
- 12.5 Kaken Pharmaceutical
- 12.5.1 Kaken Pharmaceutical Company Information
- 12.5.2 Kaken Pharmaceutical Business Overview
- 12.5.3 Kaken Pharmaceutical Revenue in Nanoemulsions Business (2021-2026)
- 12.5.4 Kaken Pharmaceutical Nanoemulsions Product Portfolio
- 12.5.5 Kaken Pharmaceutical Recent Developments
- 12.6 GlaxoSmithKline
- 12.6.1 GlaxoSmithKline Company Information
- 12.6.2 GlaxoSmithKline Business Overview
- 12.6.3 GlaxoSmithKline Revenue in Nanoemulsions Business (2021-2026)
- 12.6.4 GlaxoSmithKline Nanoemulsions Product Portfolio
- 12.6.5 GlaxoSmithKline Recent Developments
- 12.7 Novartis AG
- 12.7.1 Novartis AG Company Information
- 12.7.2 Novartis AG Business Overview
- 12.7.3 Novartis AG Revenue in Nanoemulsions Business (2021-2026)
- 12.7.4 Novartis AG Nanoemulsions Product Portfolio
- 12.7.5 Novartis AG Recent Developments
- 12.8 Sanofi
- 12.8.1 Sanofi Company Information
- 12.8.2 Sanofi Business Overview
- 12.8.3 Sanofi Revenue in Nanoemulsions Business (2021-2026)
- 12.8.4 Sanofi Nanoemulsions Product Portfolio
- 12.8.5 Sanofi Recent Developments
- 12.9 B. Braun Melsungen
- 12.9.1 B. Braun Melsungen Company Information
- 12.9.2 B. Braun Melsungen Business Overview
- 12.9.3 B. Braun Melsungen Revenue in Nanoemulsions Business (2021-2026)
- 12.9.4 B. Braun Melsungen Nanoemulsions Product Portfolio
- 12.9.5 B. Braun Melsungen Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst